Nifty Corporate Earnings Analysis –

Q4 | 2016

 

by Rajat Sharma | May 12, 2016

Yesterday we analyzed earnings trend for constituent companies of the S&P CNX Nifty. On year-on-year basis (Q4 2015 to Q4 2016) corporate earnings showed a growth of 14.7%. In comparison, average stock prices went down by 1.9% during the same period*.

* Based on stock prices as on 31st March for each year.
** Based on 26 of the 50 companies comprising the S&P CNX Nifty that have declared results as of the date of this article.

 

Current PE Valuation of the Nifty = 21.30

corporate earnings

Excel Calculation – 26 Nifty Company Result

Key Points about Corporate Earnings for Q4:

  • The analysis is based on the results of 26 out of 50 Nifty companies which have declared earnings so far.
  • Note – from April 1, 2016, Nifty has excluded Cairn, Vedanta, and PNB and included Aurobindo Pharma, Bharti Infratel, and Eicher Motors
  • Earnings are improving while stock prices are showing a declining trend.
  • On year-on-year basis there is an average growth of 14.7% in profitability. The benchmark Nifty went down 9 % in the same period.
  • On a trailing basis markets remain expensive and are trading at valuations of 21.30 (PE).
  • Most sectors have shown considerable improvement in profitability.
  • Fundamentally (besides valuations) things are looking good at macro level.
  • Pharma, Metals, Construction, Oil and Gas , Power companies are yet to announce their earnings for Q4 of FY 2016. 

 

WE WILL BE UPDATING THIS ARTICLE ONCE REST OF THE COMPANIES DECLARE THEIR RESULTS OVER THE NEXT 1 MONTH. 

BOOKMARK THIS SPACE.

 

Share this post

Don’t forget to leave a comment

Don’t forget to leave a comment

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Other Posts

Other Posts

Cadila Healthcare Stock Analysis

Cadila Healthcare Stock Analysis

Price: Rs. 253.75 Date: March 30th 2020 Cadila Healthcare Limited (“Cadila” or the “Company”) is a pharmaceutical company that discovers, develops, and manufactures a broad range of healthcare products including human formulations, veterinary formulations and drugs,...

read more

Voltas Stock Analysis

Date: 3 April 2020 Price: Rs. 472 Voltas Limited is the one of the India’s largest air conditioning company. The Company is also one of the most reputed engineering solution providers specializing in project management. The Company also provides its expertise across...

read more

Free Investment Newsletter

Join us and connect with over 65,000 subscribers who benefit from our insights on the latest
in the world of stocks and personal finance.

Free Investment Newsletter

Join us and connect with over 65,000 subscribers who benefit from our insights on the latest
in the world of stocks and personal finance.